Vor Biopharma (VOR)

• Market cap: $226M
• 1 day: -3.64%
• 5 days: 22.83%
• 1 month: -45.05%
• 3 months: -71.31%
• 6 months: 125.05%
• Year to date: -53.88%
• 1 year: -48.86%
• 5 years: -98.62%
• 10 years: -98.62%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168